Summit Corporation plc Stock London S.E.
Stocks
GB00B02T3K57
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 10.39B 14.04B 12.09B 11.37B 19.43B 1,326B 19.48B 134B 52.14B 680B 52.74B 51.59B 2,192B | P/E 2026 * |
-15.1x | P/E 2027 * | -15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 9.92B 13.41B 11.54B 10.86B 18.56B 1,266B 18.61B 128B 49.79B 650B 50.37B 49.27B 2,093B | EV / Sales 2026 * |
3,394x | EV / Sales 2027 * | 244x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Summit Corporation plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 25/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 01/04/2020 |
| Director of Finance/CFO | 48 | 02/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 01/02/2020 |
| Director/Board Member | 48 | 01/12/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 11/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | -2.27% | +50.90% | +89.03% | 67.98B | |
| -2.06% | -0.18% | +41.53% | +88.17% | 64.94B | |
| -0.31% | +6.54% | -11.39% | +457.82% | 27.58B | |
| -3.00% | -2.90% | +39.40% | +9.41% | 25.74B | |
| +0.86% | +1.65% | +0.25% | -14.78% | 26.06B | |
| -1.46% | +0.42% | +24.07% | -18.70% | 20.09B | |
| -2.96% | -15.21% | +210.71% | +370.84% | 17.16B | |
| -1.49% | -4.88% | -0.41% | +530.26% | 14.92B | |
| -0.20% | +8.37% | +57.87% | +159.50% | 14.62B | |
| Average | -1.38% | +0.26% | +45.88% | +185.73% | 31.01B | |
| Weighted average by Cap. | -1.52% | +0.18% | +42.29% | +145.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.92M 3.95M 3.4M 3.2M 5.47M 373M 5.48M 37.81M 14.67M 191M 14.84M 14.52M 617M | 41.7M 56.39M 48.52M 45.65M 78.01M 5.32B 78.22M 539M 209M 2.73B 212M 207M 8.8B |
| Net income | -690M -933M -803M -755M -1.29B -88.07B -1.29B -8.92B -3.46B -45.18B -3.5B -3.43B -146B | -730M -986M -849M -799M -1.36B -93.14B -1.37B -9.44B -3.66B -47.79B -3.7B -3.62B -154B |
| Net Debt | -467M -632M -544M -512M -874M -59.66B -877M -6.04B -2.35B -30.61B -2.37B -2.32B -98.6B | -199M -268M -231M -217M -371M -25.35B -372M -2.57B -997M -13.01B -1.01B -986M -41.9B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
